FDA Inspection 833838 — Lilly Del Caribe, Inc.
The FDA completed an inspection of Lilly Del Caribe, Inc. on May 9, 2013 in Guayama, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 9, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Guayama, PR (United States)